# HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

> **NCT00001748** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 35 (—)

## Conditions studied

- Graft vs Host Disease
- Hematologic Neoplasms
- Lymphoma
- Myelodysplastic Syndromes
- Myeloid Leukemia

## Interventions

- **PROCEDURE:** Peripheral blood progenitor cell transplant

## Key facts

- **NCT ID:** NCT00001748
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** 2000-05
- **Target enrollment:** 35 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001748, "HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00001748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*